Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
MDDCitalopramMajor Depressive Disorder
Interventions
DRUG

citalopram

citalopram 20-40 mg daily

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER

NCT01557946 - Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression | Biotech Hunter | Biotech Hunter